These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 33044704)

  • 1. Use of rituximab and the risk of adverse clinical outcomes in COVID-19 patients with systemic rheumatic disease.
    Kow CS; Hasan SS
    Rheumatol Int; 2020 Dec; 40(12):2117-2118. PubMed ID: 33044704
    [No Abstract]   [Full Text] [Related]  

  • 2. High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study.
    Loarce-Martos J; García-Fernández A; López-Gutiérrez F; García-García V; Calvo-Sanz L; Del Bosque-Granero I; Terán-Tinedo MA; Boteanu A; Bachiller-Corral J; Vázquez-Díaz M
    Rheumatol Int; 2020 Dec; 40(12):2015-2021. PubMed ID: 32945944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion.
    Sarzi-Puttini P; Marotto D; Antivalle M; Salaffi F; Atzeni F; Maconi G; Monteleone G; Rizzardini G; Antinori S; Galli M; Ardizzone S
    Autoimmun Rev; 2020 Jul; 19(7):102574. PubMed ID: 32376399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheumatology in a time of Coronavirus: lessons from our early experiences.
    Cronin O; Horne A; Ralston SH
    QJM; 2020 Oct; 113(10):715-716. PubMed ID: 32396603
    [No Abstract]   [Full Text] [Related]  

  • 5. Who Needs a Corona?
    Winthrop KL
    Arthritis Rheumatol; 2020 Jun; 72(6):874-876. PubMed ID: 32181583
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of pediatric rheumatic patients in Kazakhstan during the coronavirus disease 2019 (COVID-19) pandemic.
    Mukusheva Z; Assylbekova M; Poddighe D
    Rheumatol Int; 2020 Aug; 40(8):1351-1352. PubMed ID: 32514608
    [No Abstract]   [Full Text] [Related]  

  • 7. Care for patients with rheumatic diseases during COVID-19 pandemic: A position statement from APLAR.
    Tam LS; Tanaka Y; Handa R; Chang CC; Cheng YK; Isalm N; Li M; Lorenzo JP; Song YW; Yamamoto K; Zeng X; Haq SA
    Int J Rheum Dis; 2020 Jun; 23(6):717-722. PubMed ID: 32462761
    [No Abstract]   [Full Text] [Related]  

  • 8. [Current guidance of the German Society of Rheumatology for the care of patients with rheumatic diseases during the SARS-CoV-2/Covid 19 pandemic].
    Schulze-Koops H; Holle J; Moosig F; Specker C; Aries P; Burmester G; Fiehn C; Hoyer B; Krause A; Leipe J; Lorenz HM; Schneider M; Sewerin P; Voormann A; Wager U; Krüger K; Iking-Konert C;
    Z Rheumatol; 2020 May; 79(4):385-388. PubMed ID: 32342184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No higher risk of respiratory symptoms in Italian rheumatological patients under IL-6R-inhibitor therapy in SARS-CoV-2 pandemic.
    Alivernini S; Petricca L; Perniola S; Fedele AL; Gigante MR; Capacci A; Paglionico A; Varriano V; De Lorenzis E; Lanzo L; Melpignano F; Rubortone P; Tanti G; Tur C; Bruno D; Gigante L; Natalello G; Verardi L; Di Mario C; Tolusso B; Mirone L; Lizzio MM; Zoli A; Peluso G; Bosello SL; Gremese E
    Rheumatology (Oxford); 2020 Sep; 59(9):2644-2646. PubMed ID: 32728733
    [No Abstract]   [Full Text] [Related]  

  • 10. Self-care recommendations for patients with rheumatic diseases during the COVID-19 pandemic.
    Kim HS; Lee MS; Kim H; Sung YK; Lee J; Shim SC; Park SH; Baek HJ
    Rheumatol Int; 2020 Aug; 40(8):1347-1349. PubMed ID: 32488428
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies.
    Sanchez-Piedra C; Diaz-Torne C; Manero J; Pego-Reigosa JM; Rúa-Figueroa Í; Gonzalez-Gay MA; Gomez-Reino J; Alvaro-Gracia JM;
    Ann Rheum Dis; 2020 Jul; 79(7):988-990. PubMed ID: 32503857
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial: Reflections on rheumatological aspects of COVID-19.
    Calabrese LH; Calabrese C
    Curr Opin Rheumatol; 2020 Sep; 32(5):427-428. PubMed ID: 32675718
    [No Abstract]   [Full Text] [Related]  

  • 13. Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs.
    Michelena X; Borrell H; López-Corbeto M; López-Lasanta M; Moreno E; Pascual-Pastor M; Erra A; Serrat M; Espartal E; Antón S; Añez GA; Caparrós-Ruiz R; Pluma A; Trallero-Araguás E; Barceló-Bru M; Almirall M; De Agustín JJ; Lladós J; Julià A; Marsal S
    Semin Arthritis Rheum; 2020 Aug; 50(4):564-570. PubMed ID: 32425260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of immunosuppressive therapy in rheumatic diseases concurrent with COVID-19.
    Lu C; Li S; Liu Y
    Ann Rheum Dis; 2020 Jun; 79(6):737-739. PubMed ID: 32295789
    [No Abstract]   [Full Text] [Related]  

  • 15. [Management of Rheumatic Diseases during the COVID-19 Pandemic: Beyond Telehealth Services].
    Fernandes AL; Silva C; Miranda LC
    Acta Med Port; 2020 Oct; 33(10):706. PubMed ID: 32840207
    [No Abstract]   [Full Text] [Related]  

  • 16. National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD.
    Hasseli R; Mueller-Ladner U; Schmeiser T; Hoyer BF; Krause A; Lorenz HM; Regierer AC; Richter JG; Strangfeld A; Voll RE; Pfeil A; Schulze-Koops H; Specker C
    RMD Open; 2020 Sep; 6(2):. PubMed ID: 32878994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New data emerging on outcomes for patients with COVID-19 and rheumatic diseases.
    Onuora S
    Nat Rev Rheumatol; 2020 Aug; 16(8):407. PubMed ID: 32620941
    [No Abstract]   [Full Text] [Related]  

  • 18. Can hydroxychloroquine protect patients with rheumatic diseases from COVID-19? Response to: 'Does hydroxychloroquine prevent the transmission of COVID-19?' by Heldwein and Calado and 'SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment' by Joob and Wiwanitkit.
    Monti S; Montecucco C
    Ann Rheum Dis; 2020 Jun; 79(6):e62. PubMed ID: 32327429
    [No Abstract]   [Full Text] [Related]  

  • 19. Are my patients with rheumatic diseases at higher risk of COVID-19?
    Figueroa-Parra G; Aguirre-Garcia GM; Gamboa-Alonso CM; Camacho-Ortiz A; Galarza-Delgado DA
    Ann Rheum Dis; 2020 Jun; 79(6):839-840. PubMed ID: 32205336
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID-19 and rheumatology: is shielding really necessary?
    Amani L; Warraich R; Patel N; Tahir H
    Br J Hosp Med (Lond); 2020 Jun; 81(6):1-3. PubMed ID: 32589537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.